GSK Price to Book Ratio 2010-2023 | GSK

Historical price to book ratio values for GSK (GSK) over the last 10 years. The current price to book ratio for GSK as of May 29, 2023 is 5.10.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

GSK Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2023-05-26 34.24 inf
2023-03-31 35.23 0.00
2022-12-31 34.46 $5.79 5.95
2022-09-30 28.57 0.00
2022-06-30 52.26 0.00
2022-03-31 51.89 0.00
2021-12-31 51.77 $13.62 3.80
2021-09-30 44.30 0.00
2021-06-30 45.61 0.00
2021-03-31 40.33 0.00
2020-12-31 40.84 $12.40 3.29
2020-09-30 41.21 0.00
2020-06-30 44.13 0.00
2020-03-31 40.52 0.00
2019-12-31 49.59 $10.89 4.56
2019-09-30 44.54 0.00
2019-06-30 41.29 0.00
2019-03-31 42.61 0.00
2018-12-31 38.39 $2.28 16.85
2018-09-30 39.88 0.00
2018-06-30 39.54 0.00
2018-03-31 37.85 0.00
2017-12-31 33.76 $2.09 16.14
2017-09-30 38.10 0.00
2017-06-30 39.95 0.00
2017-03-31 38.62 0.00
2016-09-30 38.51 0.00
2016-06-30 38.30 0.00
2016-03-31 35.41 0.00
2015-12-31 34.17 0.00
2015-09-30 32.13 0.00
2015-06-30 34.36 0.00
2015-03-31 37.57 0.00
2014-12-31 34.29 0.00
2014-09-30 36.39 0.00
2014-06-30 41.77 0.00
2014-03-31 41.25 0.00
2013-12-31 40.67 0.00
2013-09-30 37.77 0.00
2013-06-30 37.22 0.00
2013-03-31 34.57 0.00
2012-12-31 31.55 0.00
2012-09-30 33.11 0.00
2012-06-30 32.27 0.00
2012-03-31 31.42 0.00
2011-12-31 31.35 0.00
2011-09-30 28.01 0.00
2011-06-30 28.76 0.00
2011-03-31 25.44 0.00
2010-12-31 25.57 0.00
2010-09-30 25.43 0.00
2010-06-30 21.61 0.00
2010-03-31 24.17 0.00
2009-12-31 26.11 0.00
2009-09-30 24.12 0.00
2009-06-30 21.32 0.00
2009-03-31 18.50 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $70.106B $36.279B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.076B 8.19
Bio-Rad Laboratories (BIO.B) United States $11.071B 29.60
QIAGEN (QGEN) Netherlands $10.491B 22.15
Ginkgo Bioworks Holdings (DNA) United States $3.170B 0.00
Arcus Biosciences (RCUS) United States $1.611B 0.00
Biohaven (BHVN) United States $1.059B 0.00
Emergent Biosolutions (EBS) United States $0.412B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.175B 0.00
Enzo Biochem (ENZ) United States $0.114B 0.00
SQZ Biotechnologies (SQZ) United States $0.017B 0.00